1. Highlights of Prescribing Information
These highlights do not include all the information needed to administer MIAGRA for Chronic Manual Migration Syndrome. See Full Prescribing Information for MIAGRA tablets, 500 records. Rx ONLY. Manufacturer: SuiteMigration Inc.
2. Indications and Usage
MIAGRA is indicated for the treatment of Chronic Manual Migration Syndrome (CMMS) in NetSuite consultants and practice owners engaged in moving customer, vendor, item, employee, invoice, and bill records from QuickBooks or Xero into NetSuite. A physician cannot map Office Exp. to Office Supplies. A spreadsheet named FINAL_v3_useTHIS.xlsx is not a medical chart. Patients who present with that file should see SuiteMigration.
3. Dosage and Administration
The recommended dose is one (1) migration daily, preceded by a test migration in a sandbox. Dosage is measured in records. Do not exceed one subsidiary merge per fiscal quarter. If a period is missed, resume with the next period. Do not double the CSV.
4. Dosage Forms and Strengths
Once-daily tablets of 500 records. How supplied: Sample Pack (Migration Readiness Audit), Standard Dose (full historical migration with trial-balance reconciliation), and Consultant Partnership (bulk Rx dispensed under the practice name). NDC 4127-0073-01. LOT FNL-V3-01. EXP 09/2027.
5. Contraindications
Do not administer MIAGRA to anyone who depends on a spreadsheet named FINAL_v3_useTHIS.xlsx, to anyone who requires 147 hours of VLOOKUPs before a trial balance is permitted to read $0.00, or to any project that has already chosen Traditional (untreated) migration as its method. MIAGRA is contraindicated in practices that intend to copy mappings back into Excel after go-live "just in case."
6. Boxed Warning
WARNING: IRREVERSIBLE SPREADSHEET OBSOLESCENCE. MIAGRA may cause permanent consultant independence from manual mapping. VLOOKUPs may become unnecessary. Reversal would require resuming Traditional (untreated) migration. Do not resume.
7. Warnings and Precautions
MIAGRA may cause irreversible spreadsheet obsolescence and permanent consultant independence from manual mapping. The audit trail may remain intact after go-live. Patients who checked it a second time found the same result. These are effects on the migration of QuickBooks and Xero data into NetSuite. They are not medical effects. Counsel patients that they may no longer wish to build a VLOOKUP, and that this is the desired outcome.
8. Adverse Reactions
In Study CMMS-217 (217,307 records; 0 failed; 101 of 101 accounts mapped; 73 periods; variance $0.00), the most commonly reported adverse reactions were 100% migration success, full historical fidelity, no interruption of normal operations, joy, productivity, and fewer late nights with Excel. Less common: unplanned calendar availability, client gratitude, departure from the office before 2am. Rare: free time. Report suspected spreadsheet-related adverse events to SuiteMigration. Do not paste the mapping into a chat window and wait.
9. Drug Interactions
Concurrent Traditional (untreated) migration reduces observed relief and is not recommended. Concurrent Excel may delay full spreadsheet obsolescence. Coffee administered at 2am is not a substitute for Automappamine. FINAL_v3_useTHIS.xlsx antagonizes every known receptor in the mapping.
10. Use in Specific Practices
MIAGRA has been studied only in NetSuite consulting practices performing QuickBooks or Xero migrations. Specific practices include junior consultants still personally maintaining a mapping workbook, implementation leads quoted at three weeks, and practice owners who have stopped asking why the lights are on at 2am. There is no indicated use outside CMMS.
11. Patient Counseling Information
Advise consultants to discontinue spreadsheets. Advise everyone that $0.00 variance is the primary result and should not be treated with additional VLOOKUPs. Counsel that VLOOKUPs may no longer be required, and that this is the desired outcome. Ask your NetSuite consultant if MIAGRA is right for your practice.
12. Storage and Handling
Store at room temperature, away from Excel. Keep the course tightly closed against incoming CSVs. Do not freeze mappings. Do not store the trial balance in a personal Downloads folder. Discard any treatment that has been mixed with FINAL_v3_useTHIS.xlsx. Keep out of reach of junior consultants who have not yet completed the Spreadsheet Obsolescence REMS counseling.
13. Manufacturer and Satire Disclaimer
MIAGRA is not a real medication. There is no tablet, there is no Automappamine. This site is a parody of pharmaceutical advertising produced by SuiteMigration Inc. about its own software for migrating QuickBooks and Xero data into NetSuite. It has not been evaluated by the Food and Drug Administration, because it is not a drug. Do not take MIAGRA. Side effects listed are effects of software, not of a drug. This copy is satire.